Lundbeck Is Said to Express Interest in Xeris Biopharma
H Lundbeck A/S has reportedly expressed interest in acquiring the commercial-stage drugmaker Xeris Biopharma Holdings Inc.
H Lundbeck A/S has expressed interest in acquiring Xeris Biopharma Holdings Inc., a US drugmaker specialized in injectable medicines, people familiar with the matter said.
READ NEXT
More on the wire
AI TLDR
Neon announced a Creative Commons SCP Foundation movie, positioning itself against A24's project. A24 faced criticism for failing to contact the SCP Wiki team or commit to the required Creative Commons licensing.
AI TLDR
House Minority Leader Hakeem Jeffries criticized President Trump for opposing federal AI regulations. Jeffries argued that allowing the industry to self-regulate is dangerous.
AI TLDR
Google unveiled Gemini 4 Argon, a new AI model designed for complex software engineering and cybersecurity tasks. The company is currently restricting access to the model to trusted users.